Status:
UNKNOWN
TCM in the Treatment of Lung Adenocarcinoma
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Conditions:
Lung Adenocarcinoma
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is to evaluate the efficacy and safety of Jin-yuan-kang granule in the treatment of lung adenocarcinoma (LUAD) preliminarily, and provide reference for further study.
Detailed Description
Lung adenocarcinoma (LUAD) is a type of non-small cell lung cancer (NSCLC) with a rapid disease progression and poor treatment effect. The LUAD patients have a short median survival time with 8-11 mon...
Eligibility Criteria
Inclusion
- A confirmed diagnosis of LADC.
- Age ranges from17years to75years.
- A KPS score ≥40.
- Without radiotherapy, immunotherapy and targeted therapy.
- Without participanting in any other trial.
- With signed informed consent.
Exclusion
- Pregnant, nursing or may become pregnant women.
- The patient has a history of allergy to any of the components of the intervention drug;
- Patients with severe liver and kidney dysfunction, cardiovascular and cerebrovascular diseases.
- Unconscious or unable to communicate normally.
- Patients with poor compliance.
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04482829
Start Date
September 15 2020
End Date
June 30 2022
Last Update
July 23 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.